Target intelligence / Profile preview

Drebrin 1 (DBN1)

Target
DBN1
Molecular classification
Other (Actin-binding protein, cytoskeletal regulator)
01

Overview

Drebrin 1 (DBN1) is a cytoplasmic, actin-binding protein crucial for neuronal development, synaptic function, and cytoskeleton organization. Encoded by the DBN1 gene, it exists as two major isoforms—drebrin A (neuron-specific, found predominantly in adult brain dendritic spines) and drebrin E (expressed earlier in development and in non-neuronal cells)[2][3][5]. Drebrin regulates the morphology and plasticity of dendritic spines and is involved in intercellular junctions and immune synapses[2][3][4]. It acts by stabilizing F-actin and coordinating actin–microtubule interactions, such as binding to microtubule plus-end proteins like EB1/EB3 and forming unique F-actin scaffolds for molecular signaling[3][4]. Reduction of drebrin has been associated with synaptic loss and cognitive impairment in Alzheimer’s disease and Down syndrome[3][4][5]. Drebrin is not a typical pharmacological target such as a receptor or enzyme, and there are no known drugs directly targeting it, but it plays a key mechanistic role in diseases linked to cytoskeletal dysregulation and neuronal connectivity[2][3][5].

Other names
DrebrinD0S117EDevelopmentally-regulated brain proteinDrebrin ADrebrin EDrebrin E2
02

Biological functions

Actin cytoskeleton organizationCell migrationSynaptic plasticityNeuronal development (neuritogenesis, growth-cone guidance)Intercellular communication
03

Disease associations

Neurodegenerative disease (e.g., Alzheimer’s disease, Down syndrome)Cancer (e.g., breast cancer metastasis, aberrant cell migration)
04

Biomarkers

Decreased drebrin levels in brain tissue may be a biomarker of synaptic dysfunction associated with Alzheimer’s disease and Down syndrome[3][4][5]

Beyond the preview

Go deeper on Drebrin 1 (DBN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drebrin 1 (DBN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call